Kimball Electronics (3C3) AI Stock Analysis

Kimball Electronics

(Frankfurt:3C3)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Deleveraging and liquiditySubstantially lower borrowings and ample liquidity strengthen Kimball Electronics’ ability to fund capital expenditures, absorb operating volatility, and pursue growth opportunities. Reduced debt should also support lower interest costs and preserve financial flexibility over the next several quarters.

Negative Factors

Multi-year revenue contractionThe prolonged sales decline indicates that recent profitability improvements have not yet been supported by a stable revenue base. Continued contraction can weaken operating leverage, reduce customer-program scale, and make margin recovery less durable even as management targets renewed growth.

Kimball Electronics (3C3) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 620.43M
Dividend Yield: ―
Average Volume (3M): 255
Price to Earnings (P/E): 22.7
Beta (1Y): 0.77
Revenue Growth: -10.24%
EPS Growth: 55.92%
Country: Germany
Employees: 5,600
Sector: Industrials
Sector Strength: 63
Industry: Electrical Equipment & Parts

Kimball Electronics Business Overview & Revenue Model

Company Description

Kimball Electronics, Inc. specializes in providing comprehensive contract electronics manufacturing (CEM) and an array of diversified production solutions, catering to clients across the automotive, medical, industrial, and public safety sectors. The...

Kimball Electronics Earnings Call Summary

Earnings Call Date:Aug 11, 2026(Q4-2026)|% Change Since:12.04%|Next Earnings Date:Nov 03, 2026

Earnings Call SentimentPositive

The call was largely constructive: management highlighted stabilization of the base business, strong cash generation, meaningful balance sheet improvement, gross margin expansion, and an accretive acquisition (Helvoet) that supports FY2027 growth guidance of 7%–9%. Medical continues to be the primary growth engine. Offsetting these positives are persistent weakness in Automotive and Industrial segments, near-term margin pressure from ramping the Indianapolis CDMO facility (an estimated ~$6.5M–$7M drag), a very high Q4 effective tax rate that distorted adjusted results, and expected working capital headwinds and FX translation risk associated with Helvoet. Overall, the positives (cash, guidance, Medical momentum, acquisition synergies, and improved margins/interest costs) outweigh the negatives, though several risks remain in the near term.

Positive Updates

Strong Cash Generation and Strengthened Balance Sheet

Operating cash flow of $42.4M in Q4 (10th consecutive quarter positive); cash & equivalents $88.9M; borrowings $116.6M (lowest in >4 years, down $30.9M or 21% YoY and down $46.4M QoQ); short-term liquidity (cash + unused credit) $411.3M.

Negative Updates

Overall Revenue Pressure in Q4

Company net sales in Q4 were $371.6M, down 2% YoY despite a 5% sequential increase, indicating persistent top-line pressure outside of Medical.

Company Guidance

Guidance for fiscal 2027 calls for net sales of $1.535–$1.56 billion (up 7%–9% vs. FY2026) comprising 3%–5% organic growth plus roughly $60 million of Helvoet revenue, with Medical expected to approach ~35% of company sales and deliver high-single to low-double digit organic growth, Industrial roughly in line with the company average, and Automotive essentially flattish; adjusted operating income is forecast at 4.4%–4.7% of sales, capital expenditures $50–$60 million, an effective tax rate in the low‑30s, and revenue fairly evenly distributed quarter-to-quarter, while management expects the Indianapolis ramp to create roughly a $6.5–$7.0 million drag (production beginning late calendar year with an ~18‑month move completion) largely offset by Helvoet accretion — all against a balance sheet with $88.9 million cash, $116.6 million borrowings (lowest in >4 years), $411.3 million of short‑term liquidity, $72.3 million of FY26 operating cash flow, and $24.4 million remaining on the share‑repurchase authorization.

Kimball Electronics Risk Analysis

Kimball Electronics disclosed 26 risk factors in its most recent earnings report. Kimball Electronics reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.We may not realize the anticipated benefits of the Helvoet acquisition or other future acquisitions.Q2, 2026

2.We may not achieve the organic growth on which our strategy depends.Q2, 2026

3.Our development, deployment, and use of artificial intelligence technologies could expose us to operational, legal, reputational, and competitive risks.Q2, 2026

Kimball Electronics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:3C3 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ESP	84Outperform	$161.71M	13.17	20.22%	3.29%	4.95%	28.35%
AME	78Outperform	$55.28B	35.10	14.55%	0.55%	12.66%	10.33%
ALNT	75Outperform	$1.46B	50.05	9.43%	0.16%	10.62%	98.88%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
RFIL	63Neutral	$83.42M	34.56	6.69%	―	13.04%	―
ULBI	57Neutral	$260.28M	-39.01	-4.95%	―	4.69%	-304.68%

* Industrials Sector Average

Performance Comparison

DE:3C3 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:3C3	Kimball Electronics Inc	24.20	-0.80	-3.20%
ALNT	Allient Inc.	85.59	29.56	52.75%
AME	Ametek Inc	241.12	43.62	22.09%
ESP	Espey Mfg. & Electronics	53.20	14.96	39.12%
RFIL	Rf Industries, Ltd.	7.69	-0.06	-0.77%
ULBI	Ultralife	15.62	8.67	124.75%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Kimball Electronics AI Stock Analysis